drugset / Trial / NCT06942390

Topical Metformin Versus Topical Ketotifen in Melasma Treatment

NCT06942390

Phase 2 Not yet recruiting 60 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to evaluate and compare the efficacy and safety of a new formulation of topical metformin (nanoparticles) versus topical ketotifen (nanoparticles), both alone and combined with micro-needling, for the treatment of melasma. It is a double-blinded, randomized, split-face controlled clinical study involving 102 female patients diagnosed with bilateral melasma.

Timeline

Start
2025-06-01
Primary completion
2026-06-30
Completion
2026-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketotifen Small molecule Topical
Subject Metformin Small molecule